Nonclinical Characterization of Bexmarilimab, a Clever-1–Targeting Antibody for Supporting Immune Defense Against Cancers

por Hollmén, Maija, Maksimow, Mikael, Rannikko, Jenna H., Karvonen, Matti K., Vainio, Marita, Jalkanen, Sirpa, Jalkanen, Markku, Mandelin, Jami
Publicado 2022

Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or sev...

por Bellingan, Geoff, Brealey, David, Mancebo, Jordi, Mercat, Alain, Patroniti, Nicolò, Pettilä, Ville, Quintel, Michael, Vincent, Jean-Louis, Maksimow, Mikael, Jalkanen, Markku, Piippo, Ilse, Ranieri, V. Marco
Publicado 2017